drugset / Trial / NCT04003181

The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon

NCT04003181

Non-randomizedFactorialOpen-labelDiagnostic

Summary

Many patients suffer from chronic diarrhoea after surgical treatment for cancer in the right side of the colon. The investigators' main hypothesis is that colon cancer patients with chronic diarrhoea have a higher risk of bile acid malabsorption compared with colon cancer patients without diarrhoea. The investigators also expect that a part of the cases of bile acid malabsorption is caused by underlying bacterial overgrowth in the small bowel. The investigators assume that patients with severe bile acid malabsorption have a lower value of FGF19 in the blood compared to patients with moderate or none bile acid malabsorption. Furthermore, it is assumed that patients with chronic diarrhoea and documented bile acid malabsorption after surgical treatment for right-sided colon cancer will get improved bowel function when treated with a bile acid binder, or antibiotics in case of bacterial overgrowth.

Timeline

Start
2017-09-28
Primary completion
2021-05-26
Completion
2021-05-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholestyramine Other / unclassified
Subject Ciprofloxacin Small molecule
Subject Colesevelam Other / unclassified
Subject Rifaximin Other / unclassified